Cargando…
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
A 42-year-old male patient with high-risk prostate adenocarcinoma underwent baseline (99m) Tc-methylene diphosphonate skeletal scintigraphy, which revealed two skeletal metastases and an area of faint radiotracer uptake in the left femoral shaft. In view of oligo-metastatic nature of the disease in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010852/ https://www.ncbi.nlm.nih.gov/pubmed/36923982 http://dx.doi.org/10.1055/s-0042-1757281 |
_version_ | 1784906264088674304 |
---|---|
author | Sharma, Anshul Dwivedi, Ankur |
author_facet | Sharma, Anshul Dwivedi, Ankur |
author_sort | Sharma, Anshul |
collection | PubMed |
description | A 42-year-old male patient with high-risk prostate adenocarcinoma underwent baseline (99m) Tc-methylene diphosphonate skeletal scintigraphy, which revealed two skeletal metastases and an area of faint radiotracer uptake in the left femoral shaft. In view of oligo-metastatic nature of the disease in the bone scan and the young age of the patient, he was a candidate for metastases-directed treatment. Single photon emission computed tomography (SPECT)/CT was performed to further characterize this lesion. It was revealed to be a small soft tissue density lesion within the fatty bone marrow density, suggesting bone marrow involvement. A more sensitive evaluation of such areas with faint radiotracer uptake may be needed in high-risk prostate cancer patients where access to advanced modalities is limited. Their significance will also need reassessment as their detection will improve with technological advancements. |
format | Online Article Text |
id | pubmed-10010852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100108522023-03-14 Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? Sharma, Anshul Dwivedi, Ankur World J Nucl Med A 42-year-old male patient with high-risk prostate adenocarcinoma underwent baseline (99m) Tc-methylene diphosphonate skeletal scintigraphy, which revealed two skeletal metastases and an area of faint radiotracer uptake in the left femoral shaft. In view of oligo-metastatic nature of the disease in the bone scan and the young age of the patient, he was a candidate for metastases-directed treatment. Single photon emission computed tomography (SPECT)/CT was performed to further characterize this lesion. It was revealed to be a small soft tissue density lesion within the fatty bone marrow density, suggesting bone marrow involvement. A more sensitive evaluation of such areas with faint radiotracer uptake may be needed in high-risk prostate cancer patients where access to advanced modalities is limited. Their significance will also need reassessment as their detection will improve with technological advancements. Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-10-28 /pmc/articles/PMC10010852/ /pubmed/36923982 http://dx.doi.org/10.1055/s-0042-1757281 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Sharma, Anshul Dwivedi, Ankur Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? |
title | Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? |
title_full | Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? |
title_fullStr | Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? |
title_full_unstemmed | Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? |
title_short | Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma? |
title_sort | is further evaluation of areas with faint mdp uptake needed in individuals with oligo-metastatic prostatic adenocarcinoma? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010852/ https://www.ncbi.nlm.nih.gov/pubmed/36923982 http://dx.doi.org/10.1055/s-0042-1757281 |
work_keys_str_mv | AT sharmaanshul isfurtherevaluationofareaswithfaintmdpuptakeneededinindividualswitholigometastaticprostaticadenocarcinoma AT dwivediankur isfurtherevaluationofareaswithfaintmdpuptakeneededinindividualswitholigometastaticprostaticadenocarcinoma |